期刊文献+

疏血通注射液对凝血功能的影响 被引量:15

Effect of Shuxuetong injection on coagulation function
下载PDF
导出
摘要 目的探讨疏血通注射液对凝血功能的影响。方法随机将92例下肢深静脉血栓形成患者分为观察组和对照组各46例。观察组应用疏血通治疗2周,对照组应用低分子肝素治疗2周,观察治疗前后凝血指标:凝血酶原时间、部分凝血活酶时间、国际标准化比值及纤维蛋白原的变化。结果观察组应用疏血通治疗2周后,患者凝血指标发生变化:凝血酶原时间和部分凝血活酶时间延长,纤维蛋白原含量降低(P<0.05)。结论疏血通注射液可影响凝血功能,应用疏血通注射液抗凝预防血栓安全、有效。 [Objective] To investigate the effect of Shuxuetong injection on coagulation function. [Methods] 92 cases with deep vein thrombosis of the lower extremity were randomly divided into Shuxuetong group and control group including 46 cases respectively. Shuxuetong group was treated with Shuxuetong injection. Control group was treated with low molecular weight heparin. The changes of coagulation indexes (PT, APTT, INR, FIB) were observed before and after treatment. [Results] After injecting Shuxuetong injection for two weeks, The changes of coagulation indexes include: APTT, PT were prolonged, and the content of fibrinogen descended. [Conclusion] Shuxuetong injection can affect coagulation function and it is effective and safe in inhibiting coagulation activity to prevent thrombosis.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2007年第19期2380-2382,共3页 China Journal of Modern Medicine
关键词 疏血通注射液 凝血功能 抗凝 Shuxuetong injection coagulation function anticoagulation
  • 相关文献

参考文献5

二级参考文献52

  • 1徐琦,王克林,李涢,丁家欣,欧兴长.水蛭抗凝多肽基因在大肠杆菌中的表达[J].中国中医基础医学杂志,2000,6(5):22-27. 被引量:1
  • 2刘刚.新的抗凝药物─—水蛭肽的研究进展[J].国外医学(药学分册),1995,22(3):133-138. 被引量:20
  • 3李秀珍.开发中的抗栓剂——水蛭素及其12肽[J].军事医学科学院院刊,1996,20(1):73-75. 被引量:4
  • 4赵庆杰,徐晓云,代亚美,李国忠,丰宏林,徐晔,王静,王德生,刘淑华,李华.早期静脉溶栓治疗急性脑梗塞的对照研究[J].中国急救医学,1997,17(2):18-20. 被引量:44
  • 5[1]Markwardt F. The development of hirudin as an antithrombotic drug. Thrombosis Research, 1994,74( 1 ): 1 ~ 23.
  • 6[2]Markwardt F. Hirudin and derivatives as anticoagulant agents. Thromb Heamost, 1991 ;66(1 ): 141 ~ 152.
  • 7[3]Vindigni V, Filippis VD, Zanotti G, et al. Probing the structure of hirudin from hirudinaria manillensis by limited proteolysis: isolation, characterization and thrombin-inhibitory properties of N-terminal fragments. Eur J Biochem,1994,226: 323 ~ 333.
  • 8[5]Nowak G, Markwardt F. Hirudin in disseminated intravascular coagulation.Haemostasis, 1991,21 (Supple 1 ): 142 ~ 148.
  • 9[6]Markwardt F, Kaiser B, Nowak G. Studies on antithrombotic effects of recombinant hirudin. Thromb Res, 1989,54(5) :377 ~ 388.
  • 10[7]Zawilska K, Zozulinska M, Turowiecka Z, et al. The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIG) in rabbits. Thromb Res, 1993,69(3): 315 ~ 320.

共引文献116

同被引文献123

引证文献15

二级引证文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部